Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 14, 2009
Company to use the net proceeds for general corporate purposes, including prepaying its bank term loan due April 2011
-
Dec 10, 2009
Company expects the offering to close on December 14, 2009, subject to standard closing conditions
-
Nov 23, 2009
A webcast of the December 1 session will be available. Learn how to tune in live or watch the replay
-
Nov 20, 2009
Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets
-
Nov 10, 2009
Company supports efforts of International Diabetes Federation to promote worldwide diabetes education and prevention
-
Nov 9, 2009
Results from two clinical studies will be presented at the Global Congress for Minimally Invasive Gynecology (AAGL)
-
Nov 9, 2009
COGNIS® CRT-D and TELIGEN® ICD are the world's smallest and thinnest high-energy devices
-
Nov 6, 2009
Company updates third quarter financial results and full-year 2009 guidance
-
Nov 2, 2009
Third-generation drug-eluting stent now available in CE Mark countries
-
Oct 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2009, as well as guidance for...
-
Oct 9, 2009
Company to webcast its conference call on October 20. Learn how to tune in
-
Oct 6, 2009
Three models of stenting system now available for palliative treatment of malignant common bile duct strictures
-
Oct 5, 2009
Study to determine which device programming strategy best minimizes the occurrence of unnecessary therapy in ICD and CRT-D patients
-
Sep 29, 2009
Agreement will settle more than a dozen lawsuits involving intellectual property in the interventional cardiology arena
-
Sep 25, 2009
Largest randomized trial to compare the use of drug-eluting stents to bare-metal stents for AMI patients
-
Sep 23, 2009
Results support benefits of paclitaxel-eluting stents in diabetic patients
-
Sep 22, 2009
Three-year TAXUS ATLAS results show safety and efficacy advantages for Boston Scientific TAXUS Liberte Stent
-
Sep 21, 2009
Both drug-eluting stents performed well in diabetic patients
-
Sep 21, 2009
Intravascular Ultrasound (IVUS) technology designed to provide physicians a 360-degree view inside the heart and coronary vessels
-
Sep 18, 2009
PLATINUM clinical program to support FDA approval of PROMUS® Element™ Stent
-
Sep 16, 2009
Scientific symposium presentations to include clinical data on TAXUS and PROMUS stents
-
Sep 14, 2009Boston Scientific's Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network
Agreement promotes access to testing solutions for female urinary incontinence
-
Sep 10, 2009
A live webcast and replay of the September 15 healthcare conference will be available.
-
Sep 4, 2009
A live webcast and replay of the September 9 session will be available.
-
Sep 2, 2009
Findings provide additional support for PCI as a viable treatment option for patients with complex coronary anatomy